Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Li, Zi Bo ^a   Zeng, Zhao Jun ^a   Chen, Qian ^a   Luo, Sai Qun ^a   Hu, Wei Xin ^a  

^a Central South University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; GANCICLOVIR; TETRACYCLINE; THYMIDINE KINASE;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER REGRESSION; CELL INFILTRATION; CONTROLLED STUDY; EX VIVO STUDY; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; NONHUMAN; OPERATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR; TUMOR VOLUME; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; VIRUS PARTICLE; VIRUS RECOMBINANT;

ADENOCARCINOMA; ANIMALS; ANTIVIRAL AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; DEPENDOVIRUS; DOXYCYCLINE; ENZYME INDUCTION; FEMALE; GANCICLOVIR; GENE EXPRESSION REGULATION, VIRAL; GENES, SYNTHETIC; GENES, TRANSGENIC, SUICIDE; GENETIC THERAPY; GENETIC VECTORS; HUMANS; INJECTIONS, INTRALESIONAL; MICE; MICE, INBRED BALB C; MICE, NUDE; REGULATORY SEQUENCES, NUCLEIC ACID; SIMPLEXVIRUS; THYMIDINE KINASE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33646684484     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-66     Document Type: Article

References (38)

1. Palmer K, Sharan N, Emtage P, Gauldie J, Muller WJ, Wan Y: Intratumoral administration of an adenovirus expressing a Kinase dead form of ErbB-2 inhibits tumor growth. Gene Therapy 2002, 9(13):898-905.
2. Sevignani C, Calin GA, Cesari R, Sarti M, Ishii H, Yendamuri S, Vecchione A, Trapasso F, Croce CM: Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines. Cancer Research 2003, 63:1183-1187.
3. Janat-Amsbury MM, Yockman JW, Lee M, Kern S, Furgeson DY, Bikram M, Kim SW: Combination of Local, Nonviral IL12 Gene Therapy and Systemic Paclitaxel Treatment in a Metastatic Breast Cancer Model. Molecular Therapy 2004, 9:829-836.
4. Nakamori M, Fu X, Rousseau R, Chen SY, Zhang X: Destruction of nonimmunogenic mammary tumor cells by a fusogenic oncolytic herpes simplex virus induces potent antitumor immunity. Molecular Therapy 2004, 9:658-665.
5. Cowan KH, Moscow JA, Huang H, Zujewski JA, O'Shaughnessy J, Sorrentino B, Hines K, Carter C, Schneider E, Cusack G, Noone M, Dunbar C, Steinberg S, Wilson W, Goldspiel B, Read EJ, Leitman SF, McDonagh K, Chow C, Abati A, Chiang Y, Chang YN, Gottesman MM, Pastan I, Nienhuis A: Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA(MDRI) in metastatic breast cancer patients. Clinical Cancer Research 1999, 5:1619-1628.
6. Li H, Lindenmeyer F, Grenet C, Opolon P, Menashi S, Soria C, Yeh P, Perricaudet M, Lu H: AdTIMP22 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice. Human Gene Therapy 2001, 12:515-526.
7. Lin T, Zhang L, Davis J, Gu J, Nishizaki M, Ji L, Roth JA, Xiong M, Fang B: Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers. Molecular Therapy 2003, 8:441-448.
8. Stribbling SM, Friedlos F, Martin J, Davies L, Spooner RA, Marais R, Springer CJ: Regressions of established breast carcinoma xenografts by carboxypeptidase G2 suicide gene therapy and the prodrug CMDA are due to a bystander effect Human Gene Therapy 2000, 11:285-292.
9. Asklund T, Appelskog IB, Ammerpohl O, Langmoen IA, Dilber MS, Aints A, Ekstrom TJ, Almqvist PM: Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene. Experimental Cell Research 2003, 284:185-195.
10. Beltinger C, Fulda S, Kammertoens T, Uckert W, Debatin KM: Mitochondrial amplification of death signals determines thymidine kinase/ ganciclovir-triggered activation of apoptosis. Cancer Research 2000, 60:3212-3217.
11. Yu L, Yamamoto N, Kadomatsu K, Muramatsu T, Matsubara, S, Sakiyama S, Tagawa M: Midkine promoter can mediate transcriptional activation of a fused suicide gene in a broader range of human breast cancer compared with c-erbB-2 promoter. Oncology 2004, 66:143-149.
12. Qiao J, Doubrovin M, Sauter BV, Huang Y, Guo ZS, Balatoni J, Akhurst T, Blasberg RG, Tjuvajev JG, Chen SH, Woo SL: Tumor-specific transcriptional targeting of suicide gene therapy. Gene Therapy 2002, 9:168-175.
13. Maeda T, O-Wang J, Matsubara H, Asano T, Ochiai T, Sakiyama S, Tagawa M: A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir. Cancer Gene Therapy 2001, 8:890-896.
14. A-Mohammadi S, Hawkins RE: Efficient transgene regulation from a single tetracycline- controlled positive feedback regulatory system. Gene Therapy 1998, 5:76-84.
15. Hillman GG, Slos P, Wang Y, Wright JL, Layer A, De Meyer M, Yudelev M, Che M, Forman JD: Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adeno-carcinoma. Cancer Gene Therapy 2004, 11:61-72.
16. Gossen M, Freundlied S, Bender G, Muller G, Hillen W, Bujard H: Trandcriptional activation by tetracyclines in mammalian cells. Science 1995, 268:1766-1769.
17. Aurisicchio L, Bujard H, Hillen W, Cortese R, Ciliberto G, La Monica N, Palombo F: Regulated and prolonged expression of mIFN(α) in immunocompetent mice mediated by a helper-dpendent adenovirus vector. Gene Therapy 2001, 8:1817-1825.
18. Zabala M, Wang L, Hernandez-Alcoceba R, Hillen W, Qian C, Prieto J, Kramer MG: Optimization of the Tet-on system to regulate interleukin 12 expression in the liver for the treatment of hepatic tumors. Cancer Research 2004, 64:2799-2804.
19. Chtarto A, Bender HU, Hanemann CO, Kemp T, Lehtonen E, Levivier M, Brotchi J, Velu T, Tenenbaum L: Tetracycline-inducible transgene expression mediated by a single AAV vector. Gene Therapy 2003, 10:84-94.
20. Gafni Y, Pelled G, Zilberman Y, Turgeman G, Apparailly F, Yotvat H, Galun E, Gazit Z, Jorgensen C, Gazit D: Gene therapy platform for bone regeneration using an exogenously regulated, AAV2-based gene expression system. Molecular Therapy 2004, 9:587-595.
21. Grimm D, Kleinschmidt JA: Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use. Human Gene Therapy 1999, 10:2445-2450.
22. Hu WX, Zeng ZJ, Luo SQ, Chen Q: Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On. Chinese Medical Journal 2004, 117:434-439.
23. Zeng ZJ, Li ZB, Luo SQ, Hu WX: Retrovirus- mediated tk gene therapy of implanted human breast cancer in nude mice under the regulation of Tet-On. Cancer Gene Therapy 2006, 13:290-297.
24. McTaggart S, Al-Rubeai M: Retroviral vectors for human gene delivery. Biotechnology Advances 2002, 20:1-31.
25. Wang Y, Hu JK, Krol A, Li YP, Li CY, Yuan F: Systemic dissemination of viral vectors during intratumoral injection. Molecular Cancer Therapy 2003, 2:1233-1242.
26. Berlinghoff S, Veldwijk MR, Laufs S, Maser HP, Jauch A, Wenz F, Jens Zeller W, Fruehauf S: Susceptibility of mesothelioma cell lines to adeno-associated virus 2 vector-based suicide gene therapy. Lung Cancer 2004, 46:179-186.
27. Enger PO, Thorsen F, Lonning PE, Bjerkvig R, Hoover F: Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively than adenovirall vectors. Hum Gene Therapy 2002, 13:1115-1125.
28. + cells and breast cancer cells. Cancer Gene Therapy 2000, 7:597-604.
29. Fitzsimons HL, McKenzie JM, During MJ: Insulators coupled to a minimal bi-directional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain. Gene Therapy 2001, 8:1675-1681.
30. Lee KH, Piao H, Son BR, Heo DS, Kim NK, Kim ST: Herpes simplex virus thymidine kinase and granulocyte marcrophage colony-stimulating factor combination gene therapy in a murine CT26 cell colon cancer model. Cancer Gene Therapy 2004, 11:570-576.
31. Goto T, Nishi T, Kobayashi O, Tamura T, Dev SB, Takeshima H, Kochi M, Kuratsu J, Sakata T, Ushio Y: Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo. Molecular Therapy 2004, 10:929-937.
32. Sobotkova E, Duskova M, Smahel M, Holan V, Janouskova O, Vonka V: Chemotherapy and immunotherapy of tumours induced by gene-modified HPV16-transformed cells. Oncology Reports 2004, 12:877-883.
33. Nestler U, Wakimoto H, Siller-Lopez F, Aguilar LK, Chakravarti A, Muzikansky A, Stemmer-Rachamimov A, Chiocca EA, Aguilar-Cordova E, Hochberg FH: The combination of adenoviral HSV TK gene therapy and radiation is effective in athymic mouse glioblastoma xenografts without increasing toxic side effects. Journal of Neuro-Oncology 2004, 67:177-188.
34. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W: Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. PNAS USA 2000, 97:7963-7968.
35. Qu Z, Thottassery JV, Van Ginkel S, Manuvakhova M, Westbrook L, Roland-Lazenby C, Hays S, Kern FG: Homogeneity and long-term stability of tetracycline-regulated gene expression with low basal activity by using the rtTA2S-M2 transactivator and insulator-flanked reporter vectors. Gene 2004, 327:61-73.
36. Xu ZL, Mizuguchi H, Mayumi T, Hayakawa T: Regulated gene expression from adenovirus vectors: a systematic comparison of various inducible systems. Gene 2003, 309:145-151.
37. Shockett PE, Zhou S, Hong X, Schatz DG: Partial reconstitution of V(D)J rearrangement and lymphocyte development in RAG-deficient mice expressing inducible, tetracycline-regulated RAG transgenes. Molecular Immunology 2004, 40:813-829.
38. Freundlieb S, Schirra-Muller C, Bujard H: A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. The Journal of Gene Medicine 1999, 1:4-12.